MBX
MBX Biosciences, Inc. Common Stock
NASDAQ · USHealthcareBiotechnology
$61.16-2.79%
Price as of Jul 20, 2026
MBX earnings
MBX Biosciences, Inc. Common Stock earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.68 · Revenue est —
Track record
Beat EPS in 5 of 6 quarters
Avg surprise +19.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 14, 2026 | $-0.62 | $-0.51 | +17.7% | — | — |
| Mar 12, 2026 | $-0.63 | $-0.49 | +22.2% | — | — |
| Nov 6, 2025 | $-0.73 | $-0.63 | +13.7% | — | — |
| Aug 7, 2025 | $-0.77 | $-0.58 | +24.7% | — | — |
| Mar 17, 2025 | $-0.59 | $-0.47 | +20.3% | — | — |
| Nov 7, 2024 | $-2.72 | $-2.78 | -2.2% | — | — |
| Dec 31, 2023 | — | $-0.26 | — | — | — |
| Sep 30, 2023 | — | $-0.32 | — | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.